Citation Impact
Citing Papers
Intestinal transit, deoxycholic acid and the cholesterol saturation of bile--three inter-related factors.
1986
Topical tofacitinib for atopic dermatitis: a phase II a randomized trial
2016
Head and neck squamous cell carcinoma
2020 Standout
Expression and characterization of a C24 bile acid 7 alpha-dehydratase from Eubacterium sp. strain VPI 12708 in Escherichia coli.
1996
Cytokines in inflammatory bowel disease
2014 Standout
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
Urine Chemokines as Biomarkers of Human Systemic Lupus Erythematosus Activity
2004
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
Bone Marrow–Derived Cells Do Not Contribute Significantly to Collagen I Synthesis in a Murine Model of Renal Fibrosis
2006 StandoutNobel
“Nephritic flares” are predictors of bad long-term renal outcome in lupus nephritis
1996
A Multicenter, Randomized, Double-Blind Trial of EverolimusVersusAzathioprine and Placebo to Maintain Steroid-Induced Remission in Patients With Moderate-to-Severe Active Crohn's Disease
2008
Synchronised therapy and high‐dose cyclophosphamide in proliferative lupus nephritis
2002
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Pathophysiology of Progressive Nephropathies
1998 Standout
The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study
2017
The role of JAK/STAT signaling pathway and its inhibitors in diseases
2020
Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: Long‐term followup of a cohort of 145 patients participating in randomized controlled studies
2002
Immunolocalization of tenascin and cellular fibronectins in diverse glomerulopathies
1993
Rheumatoid arthritis
2016 Standout
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Fungus Spores, Air Pollutants, and Other Determinants of Peak Expiratory Flow Rate in Children
1996
Harmless Herbs? A Review of the Recent Literature
1998 Standout
Long Term Efficacy of High-Dose Intravenous Methylprednisolone Pulses in Active Lupus Nephritis: A 21-month prospective study
1994
The Levels of Evidence and Their Role in Evidence-Based Medicine
2011 Standout
Environmental and Health Impacts of Air Pollution: A Review
2020 Standout
Resoultion od serve lupus nephritis associated with Tripterygium wilfordii Hook F ingestion
1993
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
2008 Standout
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Users' Guides to the Medical Literature
1998 Standout
Beware of Surrogate Outcome Measures
1996
The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations
2015
Therapeutic Plasma Exchange for the Treatment of Rapidly Progressive Glomerulonephritis
1997
An approach to evidence‐based therapeutic apheresis
2002
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey
2002 Standout
Association between short-term exposure to air pollution and COVID-19 infection: Evidence from China
2020 Standout
Stool Form Scale as a Useful Guide to Intestinal Transit Time
1997 Standout
Therapeutic Apheresis for Renal Disorders
2012
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
2012
The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25highFoxP3+regulatory T cells during repeated plasmapheresis treatments of patients
2007
Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game?
1997
Therapeutic plasma exchange for refractory SLE: A comparison of outcomes between different sub-phenotypes
2017
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
2011 StandoutNobel
The Novel Kinase Inhibitor PRT062070 (Cerdulatinib) Demonstrates Efficacy in Models of Autoimmunity and B-Cell Cancer
2014
Nitrogen dioxide exposure in vivo and human alveolar macrophage inactivation of influenza virus in vitro
1989
Deoxycholic acid and the pathogenesis of gall stones.
1988
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Users' Guides to the Medical Literature
2000 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Crohn's disease
2016 Standout
JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
2017
Bile salt biotransformations by human intestinal bacteria
2005 Standout
Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis
1998
Outdoor Air Pollution: Nitrogen Dioxide, Sulfur Dioxide, and Carbon Monoxide Health Effects
2007
Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy
1996
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Systemic Lupus Erythematosus
2011 Standout
Air pollution and health
2002 Standout
Effect of lockdown amid COVID-19 pandemic on air quality of the megacity Delhi, India
2020 Standout
Immunoadsorption and plasmapheresis are equally efficacious as adjunctive therapies for severe lupus nephritis
2010
Ulcerative colitis
2016 Standout
Quantitative morphometry of lupus nephritis: The significance of collagen, tubular space, and inflammatory infiltrate
2004
Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus
2000
Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis
2020
Plasmapheresis in the Treatment of Rapidly Progressive Glomerulonephritis
1997
Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
2018
Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail
1996
Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
2009
Tofacitinib versus Methotrexate in Rheumatoid Arthritis
2014
Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis undergoing immunosuppressive therapy
2000
Pilot clinical study of Adacolumn cytapheresis in patients with systemic lupus erythematosus
2005
Effect of domestic concentrations of nitrogen dioxide on airway responses to inhaled allergen in asthmatic patients
1994
Urban air pollution and chronic obstructive pulmonary disease: a review
2001
Comorbidity and Mortality in COPD-Related Hospitalizations in the United States, 1979 to 2001
2005 Standout
Apheresis for Renal Disease
2001
Using air pollution based community clusters to explore air pollution health effects in children
2003
Early Change in Proteinuria as a Surrogate End Point for Kidney Disease Progression: An Individual Patient Meta-analysis
2014
Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone‐free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones
2000
Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis
2000 Standout
Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study
2017
Outdoor air pollution and asthma
2014 Standout
Sequential Therapies for Proliferative Lupus Nephritis
2004
Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review
2015
Principles of Separation
2013
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Clinical and Histologic Determinants of Renal Outcome in ANCA-Associated Vasculitis
2006
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus
1995
Epidemiology of chronic obstructive pulmonary disease
2001
Plasmapheresis for the treatment of kidney diseases
2016
Chronic Kidney Disease
2016 Standout
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Biological Therapies for Atopic Dermatitis: A Systematic Review
2021
Cyclosporin A and Therapeutic Plasma Exchange in the Treatment of Severe Systemic Lupus Erythematosus
2000
Systemic Lupus Erythematosus
1994
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Current methods of the U.S. Preventive Services Task Force
2001 Standout
Asthma
2000 Standout
Effects of a new, concentrated wheat fibre preparation on intestinal transit, deoxycholic acid metabolism and the composition of bile.
1986
Epidemiological studies of the respiratory effects of air pollution
1996
Review article: novel oral‐targeted therapies in inflammatory bowel disease
2018
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Cutting Edge: Ectopic Expression of CD40 Ligand on B Cells Induces Lupus-Like Autoimmune Disease
2002 StandoutNobel
TGF‐β signaling and the fibrotic response
2004 Standout
Role of Intestinal Transit in the Pathogenesis of Gallbladder Stones
1997
Combination Therapy with Pulse Cyclophosphamide plus Pulse Methylprednisolone Improves Long-Term Renal Outcome without Adding Toxicity in Patients with Lupus Nephritis
2001
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
2016
The American college of rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials
2006
Therapeutic effect of double‐filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis
2015
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
2015
Sustained remission of lupus nephritis
2006
Psoriasis Pathogenesis and Treatment
2019 Standout
A Controlled Trial of Pulse Cydophosphamide Versus Pulse Methylprednisolone in Severe Lupus Nephritis
1994
Health effects of passive smoking. 3. Parental smoking and prevalence of respiratory symptoms and asthma in school age children
1997
New York University/Hospital for Joint Diseases experience with intravenous cyclophosphamide treatment: efficacy in steroid unresponsive lupus nephritis
1995
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Preserving ovarian function in patients receiving cyclophosphamide
1999
Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus Nephritis
1996 Standout
Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis.
1996
Toxicological data on NOx: An overview
1984
Effect of gemfibrozil on biliary lipid metabolism in normolipemic subjects
1985
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines
2015
Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
2020
Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy
2005
Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile
1995
The role of air pollution in asthma
1993
Bile acid-induced liver toxicity: Relation to the hydrophobic-hydrophilic balance of bile acids
1986
Immunomodulating effects of synchronised plasmapheresis and intravenous bolus cyclophosphamide in systemic lupus erythematosus
1995
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Indoor air quality and health
1999 Standout
Simulation of the metabolism and enterohepatic circulation of endogenous deoxycholic acid in humans using a physiologic pharmacokinetic model for bile acid metabolism
1987
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
2017
Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2
2008 StandoutNobel
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Users' Guides to the Medical Literature
1993
Toxicity and carcinogenicity of potassium bromate--a new renal carcinogen.
1990 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Shu-Ping Lan being referenced
A randomized phase 2a efficacy and safety trial of the topical J anus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
2013
Plasmapheresis Does Not Increase the Risk for Infection in Immunosuppressed Patients with Severe Lupus Nephritis
1991
Progression and Remission of Renal Disease in the Lupus Nephritis Collaborative Study
1992
Clinical Outcome of Three Discrete Histologic Patterns of Injury in Severe Lupus Glomerulonephritis
1989
Randomized Phase 2b Trial of Tofacitinib (CP-690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year
2012
Termination of a clinical trial with no treatment group difference: The Lupus Nephritis Collaborative Study
1992
Irreproducibility of the Activity and Chronicity Indices Limits Their Utility in the Management of Lupus Nephritis
1993
A Controlled Trial of Plasmapheresis Therapy in Severe Lupus Nephritis
1992
Acute Respiratory Illness in Families Exposed to Nitrogen Dioxide Ambient Air Pollution in Chattanooga, Tennessee
1982
Ultrastructural Evidence of Intrahepatic Cholestasis Before and After Chenodeoxycholic Acid Therapy in Patients With Cholelithiasis: the National Cooperative Gallstone Study
1983
AB0595 Changes in serum creatinine in patients with active rheumatoid arthritis treated with TOFACITINIB (CP-690,550)
2012
A study of acute respiratory disease in families exposed to different levels of Air pollution in the Great Salt Lake basin, Utah, 1971-1972 and 1972-1973.
1982
Ultrastructural evidence of intrahepatic cholestasis before and after chenodeoxycholic acid therapy in patients with cholelithiasis: the national cooperative gallstone study.
1983
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials
2015
The Incidence and Severity of Acute Respiratory Illness in Families Exposed to Different Levels of Air Pollution, New York Metropolitan Area, 1971–1972
1981
Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trials
2014
Pretreatment Biliary Lipid Composition in White Patients with Radiol0ucent Gallstones in the National Cooperative Gallstone Study
1982